6th Meeting on External Quality Assessment in Molecular Pathology – Naples 2017
For the sixth consecutive year, representatives of the stakeholders involved in promoting accurate diagnostic testing in pathology for effective anti-cancer drug selection gathered in the second weekend of May 2017, in Naples, Italy. This very dynamic meeting always brings much discussion of the current key issues, and importantly, proposed solutions to optimising diagnostic testing quality read more…
Quality Assurance for Clinical Immunohistochemistry
IQN Path and the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) have put together a 4-part series on Quality Assurance for Clinical Immunohistochemistry. “Evolution of Quality Assurance for Clinical Immunohistochemistry (IHC) in the Era of Precision Medicine” from the lead author Emina Torlakovic. – Part 1: Fit-for-purpose Approach to Classification of Clinical IHC Biomarkers – read more…
New Article in ESMO Open
In April this year, for the fifth consecutive year, representatives of all stakeholders involved in promoting accurate diagnostic testing for anticancer drug selection gathered in Naples in order to optimise the chance that patients will have an appropriate test which forms the basis for the decision of administering targeted treatment. The article published on ESMO read more…
XXXI International Congress of the IAP and 28th Congress of the ESP in Cologne
IQN Path took part in the XXXI International Congress of the IAP and 28th Congress of the ESP in Cologne (September 25-29). IQN Path had several presentations in the EQA Session of the Two Day Symposium for Molecular Biologists involved in Molecular Pathology Diagnostics and Research. Dr Sandi Deans presented on behalf of IQN Path read more…
Successful meeting of the In-Situ Methods Working Group
On Sunday 25th September, IQN Path held another successful working group meeting of the In-Situ Methods Working Group. Prof Mogens Vyberg and Dr Emina Torlakovic gave excellent presentations on the challenges and importance of quality in immunohistochemistry (IHC) testing with presentations on positive and negative controls for IHC and an overview of the key concepts read more…
New WHO Publication
In September last year IQN Path was invited to Geneva to the World Health Organization to represent the viewpoint of pathology in an international discussion on external quality assessment. This meeting resulted in a new publication from the WHO entitled ‘WHO manual for organising a national external quality assessment program for health laboratories and other read more…
IQN Path ASBL at the Naples 2016 Congress
The newly formed IQN Path ASBL joined the Naples 2016 Congress stakeholders involved in promoting accurate testing for anti-cancer drug selection. The conference was organised by the Italian Association of Medical Oncology (AIOM) with the European Society of Pathology (ESP) and the Italian Association of Surgical Pathology (SIAPEC-IAP), and with the endorsement of the European read more…
IQN Path teams up with LMP pathologist to standardize immunohistochemistry terminology
IQN Path, represented by the executive director, Dr Jacqueline Hall, has been in collaboration with Dr. Emina Torlakovic Laboratory Medicine Program (LMP) and Canadian Immunohistochemsitry Quality Control (CIQC) an External Quality Assessment (EQA) provider to standardize a terminology and framework for quality in immunohistochemistry (IHC). Dr. Emina Torlakovic, hematopathologist, immunohistochemistry lab director at LMP and read more…
IQN Path invited to participate in a World Health Organisation (WHO) Technical Group meeting, September 21-22nd 2015
EQA is a important part of a wider framework for quality assurance of diagnostic testing. In many countries it is now of interest to establish EQA as national schemes and in those countries with well established EQA, to maintain and promote good practise in EQA. In order to assist in the establishment of national schemes read more…